15
Views
9
CrossRef citations to date
0
Altmetric
Review

Placental exosome-mediated immune protection of the fetus: feeling groovy in a cloud of exosomes

Pages 619-634 | Published online: 10 Jan 2014

References

  • Mincheva-Nilsson L. Immune cells and molecules in pregnancy: friends or foes to the fetus? Expert Rev. Clin. Immunol.2(3), 447–460 (2006).
  • Abrahams VM, Straszewski-Chavez SL, Guller S et al. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod.10, 55–63 (2004).
  • Frängsmyr L, Baranov V, Nagaeva O et al. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod.11, 35–41 (2005).
  • Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J. Immunol.176, 1534–1542 (2006).
  • Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am. J. Reprod. Immunol.56, 345–355 (2006).
  • Mincheva-Nilsson L, Nagaeva O, Chen T et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J. Immunol.176, 3585–3592 (2006).
  • Hedlund M, Stenqvist A-C, Nagaeva O et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol.183, 340–351 (2009).
  • Ratajczak J, Miekus K, Kucia M et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic projenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia20, 847–856 (2006).
  • Rechavi O, Goldstein I, Kloog Y. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett.583, 1792–1799 (2009).
  • Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Mol. Dis.34, 214–219 (2005).
  • Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol.2, 569–579 (2002).
  • Keller S, Sanderson MP, Stoek A et al. Exosomes: from biogenesis to biological function. Immunol. Lett.107, 102–108 (2006).
  • Culler S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb. Res.123, 389–392 (2009).
  • Tooth B, Lok CAR, Böing A et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am. J. Reprod. Immunol.58, 389–402 (2007).
  • Redman CWG, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol.76, 61–67 (2007).
  • Beaudoin AR, Grondin G. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim. Biophys. Acta1071, 203–219 (1991).
  • Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell. Biol.19, 43–51 (2009).
  • Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol.9, 581–593 (2009).
  • Ratajczak J, Wysoczynski M, Hayek F et al. Membrane-derived microvesicles: important and underappreciated mediators of cell–cell communication. Leukemia20, 1487–1495 (2006).
  • Morel O, Toti F, Hugel B et al. Cellular microparticles; a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol.11, 156–164 (2004).
  • Delves GH, Stewart AB, Cooper AJ et al. Prostasomes, angiogenesis, and tissue facrot. Semin. Thromb. Hemost.33, 75–70 (2007).
  • Marzesco A-M, Janich P, Wilsch-Brauninger M et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell. Sci.118, 2849–2858 (2005).
  • Lakkaraju A, Rodriguez-Boulan E. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell. Biol.18, 199–209 (2008).
  • Diamant M, Nieuwland R, Pablo RF et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated Type 2 diabetes mellitus. Circulation106, 2442–2447 (2002).
  • Willekens FL, Were JM, Roerdinkholder-Stoelwinder B et al. Liver Kuppfer cells rapidly remove red blood cell derived vesicles from the circulation by scavenger receptors. Blood105, 2141–2145 (2005).
  • Trams EG, Lauter CJ, Salem N Jr et al. Exfoliation of membrane ecto-enzymes in form of microvesicles. Biochim. Biophys. Acta645, 63–70 (1981).
  • Johnstone RM, Adam M, Hammond JR et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem.262, 9412–9420 (1987).
  • Babst M. A protein’s final ESCRT. Traffic6, 2–9 (2005).
  • Babst M. A close-up of the ESCRTs. Dev. Cell10, 547–548 (2006).
  • Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr. Opin. Cell. Biol.20, 4–11 (2008).
  • Williams RL, Urbé S. The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell. Biol.8, 355–368 (2007).
  • Amzallag N, Passer BJ, Allanic D et al. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a non-classical pathway. J. Biol. Chem.279, 46104–46112 (2004).
  • Savina A, Fader CM, Vidal M et al. Rab 11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic6, 131–143 (2005).
  • Trajkovic K, Hsu C, Chiantia S et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science319, 1244–1247 (2008).
  • Simpson RJ, Jensen SS, Lim JWE. Proteomic profiling of exosomes: current perspectives. Proteomics8, 4083–4099 (2008).
  • Miyanishi M, Tada K, Koike M et al. Identification of Tim4 as a phosphatidyl serine receptor. Nature450, 435–439 (2007).
  • Simpson RG, Lim GWE, Moritz RL et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics6(3), 267–283 (2009).
  • Denzer K, Kleijmeer MJ, Heijnen HFG et al. Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J. Cell. Sci.113, 3365–3374 (2000).
  • Valadi H, Ekstöm K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol.9, 654–659 (2007).
  • Skog J, Würdinger T, van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol.10, 1470–1476 (2008).
  • Mincheva-Nilsson L, Baranov V. The role of placental exosomes in reproduction. Am. J. Reprod. Immunol.63(6), 520–533 (2010).
  • Mincheva-Nilsson L, Nagaeva O, Sundqvist KG et al. gdT cells of human early pregnancy decidua: evidence for cytotoxic potency. Int. Immunol.12, 585–596 (2000).
  • Martinez-Lorenzo MJ, Anel A, Gamen S et al. Activated human T cells release bioactive Fas Ligand and APO2 ligand in microvesicles. J. Immunol.163, 1274–1281 (1999).
  • Clayton A, Mitchel JP, Court J et al. Human tumor derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res.67, 7458–7466 (2007).
  • Valenti R, Huber V, Iero M et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res.67, 2912–2915 (2007).
  • Karlsson M, Lundin S, Dahlgren O et al. ‘Tolerosomes’ are produced by intestinal epithelial cells. Eur. J. Immunol.31, 2892–2900 (2001).
  • Iero M, Valenti R, Huber V et al. Tumor-released exosomes and their implications in cancer immunity. Cell Death Differ.15, 80–88 (2008).
  • Blackburn DG, Taylor JM, Padykula HA. Trophoblast concept as applied to therian mammals. J. Morphol.196, 127–136 (1988).
  • Fuchs R, Ellinger I. Endocytic and transcytic processes in villous syncytiotrophoblast: role in nutrient transport to the human fetus. Traffic5, 725–738 (2004).
  • Enders AC. Formation of syncytium from cytotrophoblast in the human placenta. Obstet. Gynecol.25, 378–386 (1965).
  • Ramsey EM. What we have learned about placental circulation. J. Reprod. Med.30, 312–317 (1885).
  • Gercel-Taylor C, O’Connor SM, Lam GK et al. Shed membrane fragment modulation of CD3-ζ during pregnancy: link with induction of apoptosis. J. Reprod. Immunol.56, 29–44 (2002).
  • Eblen AC, Gercel-Taylor C, Makajima ST et al. Modulation of T cell CD3-ζ chain expression in early pregnancy. Am. J. Reprod. Immunol.47, 167–173 (2002).
  • Eagle RA, Jafferji I, Barrow AD. Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr. Immunol. Rev.5, 22–34 (2009).
  • Agüera-Gonzalez S, Boutet P, Reyburn HT et al. Brief residence at the plasma membrane of the MHC class 1-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding. J. Immunol.182, 4800–4808 (2009).
  • Cerwenka A. New twist on the regulation of NKG2D ligand expression. J. Exp. Med.206, 265–268 (2009).
  • Zuccato E, Blott EJ, Holt O et al. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitinylation and phosphorylation. J. Cell. Sci.120, 191–199 (2007).
  • Eleme K, Taner ST, Önfelt B et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J. Exp. Med.199, 1005–1010 (2004).
  • Ashiru O, Boutet P, Fernandez-Messina L et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res.70, 481–489 (2010).
  • de Gassart A, Geminard C, Fevrier B et al. Lipid raft-associated protein sorting in exosomes. Blood102, 4336–4344 (2003).
  • O’Reilly LA, Tai L, Lee L et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature461, 659–663 (2009).
  • Thery C, Amigorena S, Raposo G et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell. Biol. Chapter 3, Unit 3.22 (2006).
  • Mathias RA. Lim JW, Ji H et al. Isolation of extracellular membranous vesicles for proteomic analysis. Methods Mol. Biol.528, 227–242 (2009).
  • Clayton A, Court J, Navabi H et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods247, 163–174 (2001).
  • Taylor DD, Gercel-Taylor C, Parker LP. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol. Oncol.115, 112–120, (2009).
  • Chen C, Skog J, Hsu CH et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip10(4), 505–511 (2009).
  • Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and trombosis. Scand. J. Immunol.66, 159–165, (2007).
  • Germain SJ, Sacks GP, Sooranna SR et al. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol.179, 5949–5956 (2007).
  • Pap E, Pallinger E, Falus A et al. T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta29, 826–832 (2008).
  • Gupta AK, Rusterholts C, Huppertz B et al. A comparative study of the effect of three different syncytiotrophoblast micro-particles on endothelial cells. Placenta26, 59–66 (2004).
  • Messerli M, May K, Hansson SR et al. Feto-maternal interactions in pregnancies: placental microparticles activate peripheral monocytes. Placenta31, 106–112 (2009).
  • Pap E, Pallinger E, Pasztoi M et al. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm. Res.58, 1–8 (2009).
  • Apps R, Gardner L, Moffet A. A critical look at HLA-G. Trends Immunol.29, 313–321 (2009).
  • Apps R, Murphy SP, Fernando R et al. Human leukocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology127, 26–39 (2009).
  • Nilsson J, Skog J, Nordstrand A et al. Prostate cancer derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer100, 1603–1607 (2009).
  • Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers for ovarian cancer. Gynecol. Oncol.110, 13–21 (2008).
  • Luo SS, Ishibashi O, Ishikawa G et al. Human villous trophoblast express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol. Reprod.81, 717–729 (2009).
  • Chim SS, Shing TK, Hung EC et al. Detection and characterization of placental micro RNAs in maternal plasma. Clin. Chem.54, 482–490 (2008).
  • Pisitkun T, Shen RF, Knepper MA. Identification and proteomic analysis of exosomes in human urine. Proc. Natl Acad. Sci. USA101, 13368–13373 (2004).
  • Asea A, Claudel JP, Laur P et al. Heat shock protein-containing exosomes in mid trimester amniotic fluids. J. Reprod. Immunol.79, 12–17 (2008).
  • Keller S, Rupp C, Stoek A et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int.72, 1095–1102 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.